Annualized market data for the Cardiovascular Diseases Therapeutics Market
The Future of Cardiovascular Diseases Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis
Summary
“The Future of Cardiovascular Diseases Therapeutics – Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis.” The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global cardiovascular diseases therapeutics market. The report analyzes the markets for cardiovascular disease therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2015 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. ( http://www.bharatbook.com/detail.asp?id=128483&rt=The-Future-of-Cardiovascular-Diseases-Therapeutics-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html )
Scope
The scope of this report includes:
- Annualized market data for the cardiovascular diseases therapeutics market from 2000 to 2008, forecast forward to 2015
- Analysis of the leading therapeutic segments including hypertension, dyslipidemia and thrombosis
- Analysis of the cardiovascular diseases therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the cardiovascular diseases therapeutics market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are Novartis AG, Sanofi-aventis, Pfizer Inc and Merck & Co
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global cardiovascular diseases therapeutics market
Reasons to buy
The report will aid Business Development and marketing executives strategizing their product launches. It will allow you to;
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the cardiovascular diseases therapeutics market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the cardiovascular diseases therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global cardiovascular diseases therapeutics landscape? – Identify, understand and capitalize.
To know more and to buy a copy of your report feel free to visit : http://www.bharatbook.com/detail.asp?id=128483&rt=The-Future-of-Cardiovascular-Diseases-Therapeutics-Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html
Or
Contact us at :
Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Blog: http://bharatbookresearch.blogspot.com
Follow us on twitter: http://twitter.com/3bbharatbook
We are the leading information aggregator, facilitates and supports the business information needs. With over 115,000 reports, you can get instant access and insights on the studies in yo for market research , corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more ur areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com
Article Source:http://www.articlesbase.com/cancer-articles/annualized-market-data-for-the-cardiovascular-diseases-therapeutics-market-1583119.html
Related articles by Zemanta
- DotW: Last-Minute Shopping (invivoblog.blogspot.com)
- Chemistry Today Ddt Pannelay Jan2009 (slideshare.net)
- Vaccines on horizon for Alzheimer’s, herpes, AIDS (ctv.ca)
- Vaccines on horizon for AIDS, Alzheimer’s, herpes (seattletimes.nwsource.com)
- Deals of the Week: Merry Chrismahanukwanzakah (invivoblog.blogspot.com)
- Impactiviti Daily 091609 (impactiviti.wordpress.com)
- Strategic trends in the Pharmaceutical industry (pharmastrategyblog.com)
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=ddc57653-86d1-470d-bbd3-b496ec22b214)
Share this:
Read also:
- Prostate Health - Five Options Available
- Children of the Birth Defects at risk Brain Cancer And Spinal Tumor
- Diagnostic Tests for Prostate Cancer
- Mesothelioma - Your Basic Information
- What Food Can I Eat And What Food to Avoid to Beat Cancer?
- The Cured For Almost Every Disease Known To Man,from Cancer To Hiiv